Why vets aren’t being treated with life-saving hepatitis C drug

A Congressional hearing begins Wednesday in response to a CBS News investigation. In December, we showed how a costly new cure for hepatitis C isn’t making it to most of the 200,000 U.S. veterans infected with the disease, many as a result of their service. Congress has given $2.7 billion taxpayer dollars to treat veterans with hepatitis C, but only 15 percent have been treated with the drug, one that might not exist without government funding. Chip Reid reports. Source